[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100432493":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":25,"centralContacts":29,"locations":38,"responsibleParty":65,"collaborators":23,"id":67,"slug":23,"hasResults":68,"nctId":69,"briefTitle":70,"officialTitle":71,"acronym":72,"eligibilityCriteria":73,"healthyVolunteers":68,"sex":74,"minAge":75,"maxAge":76,"enrollmentInfo":77,"targetDuration":23,"studyType":80,"phases":81,"briefSummary":83,"conditions":84,"keywords":88,"overallStatus":40,"whyStopped":23,"lastUpdateSubmitDate":93,"lastUpdatePostDateStruct":94,"startDateStruct":97,"completionDateStruct":99,"leadSponsor":101,"locationsCount":102},{"fullName":5,"class":6},"Modum Bad","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Inpatient treatment","ACTIVE_COMPARATOR","High intensity high dosage inpatient short-term psychodynamic psychotherapy",[13],"Behavioral: Psychotherapy",{"label":15,"type":16,"description":17,"interventionNames":18},"Outpatient treatment","EXPERIMENTAL","Low dosage outpatient short-term psychodynamic psychotherapy",[13],[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":23},"BEHAVIORAL","Psychotherapy",null,[9,15],[26],{"name":27,"affiliation":5,"role":28},"Pål Ulvenes, PhD","PRINCIPAL_INVESTIGATOR",[30,34],{"name":27,"role":31,"phone":32,"phoneExt":23,"email":33},"CONTACT","32749857","pal.ulvenes@modum-bad.no",{"name":35,"role":31,"phone":36,"phoneExt":23,"email":37},"Linne Melsom, Cand.Psy","32749700","linne.melsom@modum-bad.no",[39],{"facility":5,"status":40,"city":41,"state":42,"zip":43,"country":44,"countryCode":45,"cosmosGeoPoint":46,"geoPoint":51,"contacts":52},"RECRUITING","Vikersund","Buskerud","3370","Norway","NO",{"type":47,"coordinates":48},"Point",[49,50],9.99107,59.96838,{"lat":50,"lon":49},[53,55,59,60,63],{"name":54,"role":31,"phone":32,"phoneExt":23,"email":33},"Pål G Ulvenes, PhD",{"name":56,"role":31,"phone":57,"phoneExt":23,"email":58},"Terje Tilden, PhD","32749800","terje.tilden@modum-bad.no",{"name":54,"role":28,"phone":23,"phoneExt":23,"email":23},{"name":61,"role":62,"phone":23,"phoneExt":23,"email":23},"Asle Hoffart, PhD","SUB_INVESTIGATOR",{"name":64,"role":62,"phone":23,"phoneExt":23,"email":23},"Bruce E Wampold, PhD",{"type":66,"investigatorFullName":23,"investigatorTitle":23,"investigatorAffiliation":23,"oldNameTitle":23,"oldOrganization":23},"SPONSOR","100432493",false,"NCT04911829","Dysthymia: Associated Costs, Treatment and Change Process","DepressionForefront: Costs, Treatment and Change Process for Dysthymia","DFront","Inclusion Criteria:\n\n* Inclusion criteria will be liberal and similar to clinical practice criteria at the treatment site: Persistent depressive disorder as defined by the diagnostic and statistical manual of mental disorders (DSM5); which includes an International classification of disorders-10 (ICD-10) diagnosis of depression, dysthymia, recurrent depression. unsuccessful previous treatments. living within driving distance from the treatment facilities.\n\nExclusion Criteria:\n\n* current suicidal risk, current psychosis, marked emotional instability (i.e. issues with impulsivity), strong paranoid traits, current problems related to heavy substance abuse.","ALL","18 Years","70 Years",{"count":78,"type":79},80,"ESTIMATED","INTERVENTIONAL",[82],"NA","The study evaluates cost and effect of inpatient versus outpatient treatment of dysthymia, as well as investigates the processes through which psychotherapy works in treating dysthymia.",[85,86,87],"Depression","Cost Benefit Analysis","Psychotherapeutic Processes",[89,90,91,92],"Dysthymia","Persistent depressive disorder","Chronic depression","Recurrent depression","2021-05-31",{"date":95,"type":96},"2021-06-03","ACTUAL",{"date":98,"type":96},"2016-01",{"date":100,"type":79},"2026-12",{"name":5,"class":6},1]